OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.
Quick Stats
Feb 02, 202648.2
AI Score
HOLD1.04
Volume Ratio
Apr 06, 2026
Next Earnings
12
+ve Days (30d)
13
-ve Days (30d)
OSTX Stock Summary
Last updated Feb 02, 2026
OSTX is currently trading at $1.39, positioned below its 200-day moving average of $1.81, suggesting bearish momentum. The stock has a 52-week range of $1.12 to $2.98.
Technical Analysis: The 50-day moving average stands at $1.6, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.97, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.243, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates OSTX at 48.2/100 with a HOLD recommendation.
OSTX (OS Therapies Incorporated) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.97 |
| CMF (20) | -0.243 |
| ROC (10) | -4.795 |
| ADX (14) | 20.653 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.055 |
| AROONOSC (14) | -85.714 |
| WILLAMS %R (14) | -75.758 |
| MFI (14) | 45.171 |
OSTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
OSTX Price vs Max Options Open Interest
OSTX Max Change In Options Open Interest
OSTX Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OSTX Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OSTX Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OSTX Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OS Therapies Incorporated is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
OSTX Moving Averages Analysis
OSTX (OS Therapies Incorporated) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 1.44 |
| 20 | 1.47 |
| 30 | 1.48 |
| 50 | 1.6 |
| 100 | 1.79 |
| 200 | 1.81 |
OSTX Fundamental Analysis
| P/E (Forward) | 1.6562 |
| P/E (Trailing) | -- |
| Market Cap ($) | 47.9 million |
| Earnings/Share ($) | -0.8 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.6875 |
| EPS Estimate Next Year ($) | -0.3325 |
| WallStreet Target Price ($) | 11.488 |
| Most Recent Quarter |